Rights and permissions
About this article
Cite this article
Adalimumab the pick of the bunch for psoriasis in the US. Pharmacoecon. Outcomes News 608, 6 (2010). https://doi.org/10.2165/00151234-201006080-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006080-00016